| scholarly article | Q13442814 |
| P50 | author | Mathias Ziegler | Q42723114 |
| Corinna Lau | Q79949782 | ||
| Mathias Dahlmann | Q81104533 | ||
| P2093 | author name string | Felicitas Berger | |
| P2860 | cites work | Tankyrase, a poly(ADP-ribose) polymerase at human telomeres | Q22008022 |
| Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase | Q24290390 | ||
| Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis | Q24290921 | ||
| Structural and functional characterization of human NAD kinase | Q24291777 | ||
| Mammalian NADH diphosphatases of the Nudix family: cloning and characterization of the human peroxisomal NUDT12 protein | Q24304101 | ||
| Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas | Q24530614 | ||
| Functional aspects of protein mono-ADP-ribosylation | Q24675892 | ||
| Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis | Q27636976 | ||
| Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin | Q27637274 | ||
| Crystal structure of human nicotinamide mononucleotide adenylyltransferase in complex with NMN | Q27638867 | ||
| Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis | Q27640452 | ||
| Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae | Q27933365 | ||
| Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels | Q27933382 | ||
| Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans | Q27937147 | ||
| A novel NADH kinase is the mitochondrial source of NADPH in Saccharomyces cerevisiae | Q27937404 | ||
| Identification and characterization of YLR328W, the Saccharomyces cerevisiae structural gene encoding NMN adenylyltransferase. Expression and characterization of the recombinant enzyme | Q27938021 | ||
| Identification of a novel human nicotinamide mononucleotide adenylyltransferase | Q28118710 | ||
| Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans | Q28131824 | ||
| Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles | Q28138791 | ||
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | Q28203572 | ||
| Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse | Q28206635 | ||
| Biochemistry, biology, and pharmacology of cyclic adenosine diphosphoribose (cADPR) | Q28255928 | ||
| The Sir2 family of protein deacetylases | Q28266179 | ||
| The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity | Q28611173 | ||
| Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration | Q29616075 | ||
| Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions | Q29617672 | ||
| The new life of a centenarian: signalling functions of NAD(P). | Q33976408 | ||
| Tannins elevate the level of poly(ADP-ribose) in HeLa cell extracts. | Q33977475 | ||
| Pathophysiological relevance of mitochondria in NAD(+) metabolism. | Q34180523 | ||
| Cyclic ADP ribose as a calcium-mobilizing messenger | Q34467662 | ||
| The therapeutic potential of poly(ADP-ribose) polymerase inhibitors | Q34838585 | ||
| A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse | Q35286946 | ||
| Multiplicity of Ca2+ messengers and Ca2+ stores: a perspective from cyclic ADP-ribose and NAADP. | Q35752797 | ||
| Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism | Q40585232 | ||
| Nicotinamide-mononucleotide adenylyltransferase from Methanococcus jannaschii. | Q42645699 | ||
| Identification of the archaeal NMN adenylytransferase gene | Q43026453 | ||
| Nicotinamide-mononucleotide adenylyltransferase from Sulfolobus solfataricus | Q43551718 | ||
| Cloning and characterization of two NAD kinases from Arabidopsis. identification of a calmodulin binding isoform | Q44973391 | ||
| ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose). | Q52970520 | ||
| NAD biosynthesis in human placenta: purification and characterization of homogeneous NMN adenylyltransferase | Q68043928 | ||
| Novel inhibitors of poly(ADP-ribose) glycohydrolase | Q72634399 | ||
| 21 Purification of human nicotinamide-mononucleotide adenylyltransferase | Q73484761 | ||
| Neuroscience. NAD to the rescue | Q80450186 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | niacinamide | Q192423 |
| nucleotide biosynthetic process | Q14819381 | ||
| Nicotinamide nucleotide adenylyltransferase 1 | Q21109679 | ||
| nicotinamide nucleotide adenylyltransferase 3 | Q21118870 | ||
| Nicotinamide nucleotide adenylyltransferase 2 | Q21118871 | ||
| P304 | page(s) | 36334-36341 | |
| P577 | publication date | 2005-08-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms | |
| P478 | volume | 280 |
| Q36456049 | 32P labeling of protein phosphorylation and metabolite association in the mitochondria matrix |
| Q36321255 | A conserved NAD+ binding pocket that regulates protein-protein interactions during aging |
| Q33878859 | A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis |
| Q90100823 | A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation |
| Q30638030 | A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration |
| Q64269308 | Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy |
| Q92604977 | Altered mitochondrial bioenergetics are responsible for the delay in Wallerian degeneration observed in neonatal mice |
| Q36360700 | Alternative splicing of Drosophila Nmnat functions as a switch to enhance neuroprotection under stress |
| Q37534085 | An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma |
| Q33459014 | Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte |
| Q43151003 | AtNUDX6, an ADP-ribose/NADH pyrophosphohydrolase in Arabidopsis, positively regulates NPR1-dependent salicylic acid signaling |
| Q92908091 | Axon death signalling in Wallerian degeneration among species and in disease |
| Q29013985 | Axon degeneration: Molecular mechanisms of a self-destruction pathway |
| Q37990880 | Axonal degeneration as a therapeutic target in the CNS. |
| Q35633387 | Axonal degeneration is mediated by the mitochondrial permeability transition pore. |
| Q39077240 | Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration |
| Q90044482 | Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway |
| Q27649855 | Bifunctional NMN Adenylyltransferase/ADP-Ribose Pyrophosphatase: Structure and Function in Bacterial NAD Metabolism |
| Q33598840 | Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage |
| Q51698575 | Biosensor reveals multiple sources for mitochondrial NAD⁺. |
| Q92034651 | Boosting NAD+ with a small molecule that activates NAMPT |
| Q35747152 | CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy |
| Q35028393 | Caloric excess or restriction mediated modulation of metabolic enzyme acetylation-proposed effects on cardiac growth and function |
| Q93174156 | Chemical and Physiological Features of Mitochondrial Acylation |
| Q92877736 | Chemoenzymatic Preparation of 4'-Thioribose NAD |
| Q37790654 | Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets |
| Q27662749 | Complexes of Bacterial Nicotinate Mononucleotide Adenylyltransferase with Inhibitors: Implication for Structure-Based Drug Design and Improvement |
| Q28304473 | Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging |
| Q38801880 | Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production |
| Q39886081 | Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes. |
| Q26749486 | Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3 |
| Q35652041 | Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase |
| Q38121170 | Diversification of NAD biological role: the importance of location |
| Q47666634 | Editor's Highlight: The Altered DNA Methylome of Chronic Doxorubicin Exposure in Sprague Dawley Rats |
| Q35601369 | Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart |
| Q26741300 | Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders |
| Q21145800 | Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons |
| Q24314812 | Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters |
| Q103825966 | Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import |
| Q28594953 | Expression, Localization, and Biochemical Characterization of Nicotinamide Mononucleotide Adenylyltransferase 2 |
| Q40730004 | Extracellular NAD and ATP: Partners in immune cell modulation. |
| Q90651352 | Facile chemoenzymatic synthesis of a novel stable mimic of NAD |
| Q90579711 | Flow Cytometry Analysis of Free Intracellular NAD+ Using a Targeted Biosensor |
| Q40054292 | Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix |
| Q98292031 | Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration |
| Q34385910 | Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection |
| Q35006448 | Hexose-6-phosphate dehydrogenase in the endoplasmic reticulum. |
| Q58775085 | High protein intake is associated with low plasma NAD+ levels in a healthy human cohort |
| Q41454387 | Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship |
| Q90113863 | Hypothalamic NAD+-Sirtuin Axis: Function and Regulation |
| Q97528486 | Identification and sub-cellular localization of a NAD transporter in Leishmania braziliensis (LbNDT1) |
| Q53782879 | Identification of a nicotinamide/nicotinate mononucleotide adenylyltransferase in Giardia lamblia (GlNMNAT). |
| Q35903899 | Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo |
| Q64057672 | Implications of altered NAD metabolism in metabolic disorders |
| Q52726042 | Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation. |
| Q35025319 | Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria |
| Q89581166 | Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family |
| Q36472557 | Intrinsic protein kinase activity in mitochondrial oxidative phosphorylation complexes. |
| Q33897963 | Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases |
| Q93167826 | Kinetic and oligomeric study of Leishmania braziliensis nicotinate/nicotinamide mononucleotide adenylyltransferase |
| Q54452673 | Lack of nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2): consequences for mouse bladder development and function. |
| Q35989762 | Local axonal protection by WldS as revealed by conditional regulation of protein stability |
| Q53997564 | Localization and phosphorylation of Plasmodium falciparum nicotinamide/nicotinate mononucleotide adenylyltransferase (PfNMNAT) in intraerythrocytic stages |
| Q42516548 | MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD+ consumption. |
| Q37207639 | Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection |
| Q29614496 | Mammalian sirtuins: biological insights and disease relevance |
| Q42008823 | Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition |
| Q90094424 | Metabolic aspects of neuronal degeneration: From a NAD+ point of view |
| Q34572320 | Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues |
| Q38308759 | Metabolic regulation of histone post-translational modifications. |
| Q90069416 | Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD) |
| Q37333695 | Microbial NAD metabolism: lessons from comparative genomics |
| Q28689883 | Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria. |
| Q90140037 | Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer |
| Q38170006 | Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury |
| Q37864604 | Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection |
| Q28391740 | Mitochondrial health, the epigenome and healthspan |
| Q47982041 | Modulating NAD+ metabolism, from bench to bedside. |
| Q34129753 | Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes |
| Q43298134 | Modulation of the poly(ADP-ribosyl)ation reaction via the Arabidopsis ADP-ribose/NADH pyrophosphohydrolase, AtNUDX7, is involved in the response to oxidative stress |
| Q36749025 | Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila |
| Q38803307 | Molecular mechanisms in the initiation phase of Wallerian degeneration |
| Q37057166 | Mouse Models of NMNAT1-Leber Congenital Amaurosis (LCA9) Recapitulate Key Features of the Human Disease |
| Q28271973 | Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy |
| Q35199412 | Mycobacterial nicotinate mononucleotide adenylyltransferase: structure, mechanism, and implications for drug discovery |
| Q60958368 | NAD Metabolism in Cancer Therapeutics |
| Q37446707 | NAD and axon degeneration: from the Wlds gene to neurochemistry |
| Q35805959 | NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus |
| Q34518882 | NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration |
| Q38667022 | NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism |
| Q99237973 | NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death |
| Q89673872 | NAD+ Repletion Rescues Female Fertility during Reproductive Aging |
| Q88574406 | NAD+ cellular redox and SIRT1 regulate the diurnal rhythms of tyrosine hydroxylase and conditioned cocaine reward |
| Q97643504 | NAD+ homeostasis in health and disease |
| Q50128435 | NAD+ in Aging: Molecular Mechanisms and Translational Implications |
| Q90438582 | NAD+ in Brain Aging and Neurodegenerative Disorders |
| Q91691824 | NAD+ metabolism governs the proinflammatory senescence-associated secretome |
| Q100490695 | NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential |
| Q33533467 | NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity |
| Q47950496 | NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy |
| Q38673283 | NADH oxidase activity of indoleamine 2,3-dioxygenase |
| Q91713477 | NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation |
| Q64070787 | NAMPT as a Dedifferentiation-Inducer Gene: NAD as Core Axis for Glioma Cancer Stem-Like Cells Maintenance |
| Q88412753 | NMNAT1 E257K variant, associated with Leber Congenital Amaurosis (LCA9), causes a mild retinal degeneration phenotype |
| Q24594444 | NMNAT1 mutations cause Leber congenital amaurosis |
| Q50294804 | NMNAT1 transfers an adenylyl group from ATP to NAMN to yield NAAD |
| Q50294798 | NMNAT2 transfers an adenylyl group from ATP to NAMN to yield NAAD |
| Q50294803 | NMNAT2 transfers an adenylyl group from ATP to NMN to yield NAD+ |
| Q36038362 | NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. |
| Q51246484 | NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy. |
| Q42373789 | NMNAT3 is protective against the effects of neonatal cerebral hypoxia-ischemia. |
| Q50294805 | NMNAT3 transfers an adenylyl group from ATP to NAMN to yield NAAD |
| Q37379693 | NMNATs, evolutionarily conserved neuronal maintenance factors. |
| Q97643292 | NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase |
| Q36536935 | Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? |
| Q26826912 | Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration |
| Q34088466 | Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons |
| Q34042969 | New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases |
| Q26745678 | New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology |
| Q38678550 | Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration. |
| Q39740885 | Nicotinamide Mononucleotide Adenylyl Transferase 2: A Promising Diagnostic and Therapeutic Target for Colorectal Cancer |
| Q48247454 | Nicotinamide Mononucleotide Adenylyltransferase 1 Protects Neural Cells Against Ischemic Injury in Primary Cultured Neuronal Cells and Mouse Brain with Ischemic Stroke Through AMP-Activated Protein Kinase Activation |
| Q61812177 | Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule |
| Q55399718 | Nicotinamide adenine dinucleotide is transported into mammalian mitochondria. |
| Q35182446 | Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide |
| Q34452334 | Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo |
| Q46013921 | Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. |
| Q39139918 | Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin |
| Q58760694 | Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock |
| Q35486021 | Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice |
| Q34607796 | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme |
| Q37183202 | Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress |
| Q35855758 | Nmnat1-Rbp7 Is a Conserved Fusion-Protein That Combines NAD+ Catalysis of Nmnat1 with Subcellular Localization of Rbp7 |
| Q54521190 | Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6. |
| Q35891449 | Nmnat3 Is Dispensable in Mitochondrial NAD Level Maintenance In Vivo |
| Q38994977 | Non-metabolic functions of glycolytic enzymes in tumorigenesis |
| Q33706297 | Novel compound heterozygous NMNAT1 variants associated with Leber congenital amaurosis |
| Q39314921 | Novel synthetic route to the C-nucleoside, 2-deoxy benzamide riboside |
| Q24669960 | Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? |
| Q24612868 | Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival |
| Q57444273 | Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance |
| Q33698363 | Overexpression of Wld(S) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish. |
| Q27024171 | Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells |
| Q58545365 | P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal culture |
| Q37661664 | PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes |
| Q56987263 | Pathway analysis of NAD+metabolism |
| Q34179395 | Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. |
| Q99604929 | Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration |
| Q51229411 | Protective effect of P7C3 on retinal ganglion cells from optic nerve injury. |
| Q38616779 | Protein acetylation in metabolism - metabolites and cofactors |
| Q36099563 | Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors |
| Q33729271 | Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex |
| Q33727013 | Proteomic Analysis between U87MG and U343MG-A Cell Lines: Searching for Candidate Proteins for Glioma Invasion |
| Q53818007 | Proteomic analysis through larval development of Solea senegalensis flatfish. |
| Q36581224 | Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci |
| Q57072624 | Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer |
| Q34629538 | Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration |
| Q92620209 | Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation |
| Q24681295 | Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1 |
| Q35874520 | Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase |
| Q47777258 | Rescue of peripheral and CNS axon defects in mice lacking NMNAT2. |
| Q51634956 | Restoration of Mitochondrial NAD+ Levels Delays Stem Cell Senescence and Facilitates Reprogramming of Aged Somatic Cells. |
| Q33899993 | Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases |
| Q59798260 | Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes |
| Q64912070 | Roles of Nmnat1 in the survival of retinal progenitors through the regulation of pro-apoptotic gene expression via histone acetylation. |
| Q37625383 | SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions |
| Q37296133 | SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2 |
| Q28592294 | SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle |
| Q99242930 | SLC25A51 is a mammalian mitochondrial NAD+ transporter |
| Q36211215 | Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes |
| Q34541823 | Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues |
| Q38540810 | Sirtuins and the Metabolic Hurdles in Cancer |
| Q37976307 | Sirtuins mediate mammalian metabolic responses to nutrient availability |
| Q56587035 | Structural insights into Plasmodium falciparum nicotinamide mononucleotide adenylyltransferase: oligomeric assembly |
| Q36282881 | Subcellular Distribution of NAD+ between Cytosol and Mitochondria Determines the Metabolic Profile of Human Cells. |
| Q90280891 | Subcellular NAMPT-mediated NAD+ salvage pathways and their roles in bioenergetics and neuronal protection after ischemic injury |
| Q93027996 | Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies |
| Q34682178 | Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. |
| Q27657225 | Targeting NAD Biosynthesis in Bacterial Pathogens: Structure-Based Development of Inhibitors of Nicotinate Mononucleotide Adenylyltransferase NadD |
| Q52604133 | Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. |
| Q27318568 | The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein |
| Q38047182 | The NAD metabolome--a key determinant of cancer cell biology |
| Q37175088 | The NAD+ synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribosomal RNA transcription |
| Q38717667 | The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target |
| Q39053378 | The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody. |
| Q34443624 | The biochemical pathways of central nervous system neural degeneration in niacin deficiency |
| Q90595734 | The chemistry of the vitamin B3 metabolome |
| Q36933021 | The dynamic regulation of NAD metabolism in mitochondria |
| Q42234166 | The effect of Walterinnesia aegyptia venom proteins on TCA cycle activity and mitochondrial NAD(+)-redox state in cultured human fibroblasts |
| Q37398734 | The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology |
| Q58091915 | The nanomolar sensing of nicotinamide adenine dinucleotide in human plasma using a cycling assay in albumin modified simulated body fluids |
| Q38253020 | The neuroimmunology of degeneration and regeneration in the peripheral nervous system. |
| Q24675007 | The power to reduce: pyridine nucleotides--small molecules with a multitude of functions |
| Q37193985 | The purine nucleosides adenosine and guanosine delay axonal degeneration in vitro |
| Q37388246 | The role of NAD biosynthesis in plant development and stress responses |
| Q37961433 | The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging |
| Q33779682 | The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways |
| Q90566316 | The taming of PARP1 and its impact on NAD+ metabolism |
| Q42371460 | The β-NAD+ salvage pathway and PKC-mediated signaling influence localized PARP-1 activity and CTCF Poly(ADP)ribosylation |
| Q51765163 | Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. |
| Q37229140 | Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo |
| Q35225791 | Use of (32)P to study dynamics of the mitochondrial phosphoproteome |
| Q45277283 | Wallerian degeneration slow mouse neurons are protected against cell death caused by mechanisms involving mitochondrial electron transport dysfunction |
| Q34106847 | Wallerian degeneration, wld(s), and nmnat |
| Q38212791 | Wallerian degeneration: an emerging axon death pathway linking injury and disease |
| Q37825829 | Wld(S), Nmnats and axon degeneration--progress in the past two decades |
Search more.